April 3, 2008 -- Commonwealth Biotechnologies, Inc. (NSDQCM: CBTE) and Venturepharm Laboratories Ltd (HKEX: 8225) have formed a China-based joint venture that will provide a continuous spectrum of outsourcing services. The move came after Venturepharm bought a 39% stake in CBI. The 2.15 million block of shares, which had previously belonged to PharmAust Ltd., has a market value of $5.85 million. More details...
